Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessia Favaron

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Reproductive Biomedicine Online|February 15, 2024
Do probiotic interventions improve female unexplained infertility? A critical commentaryAlessia Favaron, Engin Turkgeldi, Moe Elbadawi, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 17, 2022
Colonic drug delivery: Formulating the next generation of colon-targeted therapeuticsLaura E McCoubrey, Alessia Favaron, Atheer Awad, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|April 11, 2025
Investigating the bidirectional interactions between senotherapeutic agents and human gut microbiotaNannapat Sangfuang, Yuan Xie, Laura E McCoubrey, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|July 6, 2024
Exploring the interactions of JAK inhibitor and S1P receptor modulator drugs with the human gut microbiome: Implications for colonic drug delivery and inflammatory bowel diseaseAlessia Favaron, Youssef Abdalla, Laura E McCoubrey, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|October 5, 2024
Characterising and preventing the gut microbiota's inactivation of trifluridine, a colorectal cancer drugLaura E McCoubrey, Chenghao Shen, Sydney Mwasambu, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 19, 2024
Can in vitro/in silico tools improve colonic concentration estimations for oral extended-release formulations? A case study with upadacitinibAlessia Favaron, Bart Hens, Maiara Camotti Montanha, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|November 8, 2025
Assessing the effects of tofacitinib on the gut microbiome in inflammatory bowel diseaseAlessia Favaron, Nannapat Sangfuang, Laura E McCoubrey, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Reproductive Biomedicine Online|February 15, 2024
Do probiotic interventions improve female unexplained infertility? A critical commentaryAlessia Favaron, Engin Turkgeldi, Moe Elbadawi, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 17, 2022
Colonic drug delivery: Formulating the next generation of colon-targeted therapeuticsLaura E McCoubrey, Alessia Favaron, Atheer Awad, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|April 11, 2025
Investigating the bidirectional interactions between senotherapeutic agents and human gut microbiotaNannapat Sangfuang, Yuan Xie, Laura E McCoubrey, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|July 6, 2024
Exploring the interactions of JAK inhibitor and S1P receptor modulator drugs with the human gut microbiome: Implications for colonic drug delivery and inflammatory bowel diseaseAlessia Favaron, Youssef Abdalla, Laura E McCoubrey, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|October 5, 2024
Characterising and preventing the gut microbiota's inactivation of trifluridine, a colorectal cancer drugLaura E McCoubrey, Chenghao Shen, Sydney Mwasambu, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 19, 2024
Can in vitro/in silico tools improve colonic concentration estimations for oral extended-release formulations? A case study with upadacitinibAlessia Favaron, Bart Hens, Maiara Camotti Montanha, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|November 8, 2025
Assessing the effects of tofacitinib on the gut microbiome in inflammatory bowel diseaseAlessia Favaron, Nannapat Sangfuang, Laura E McCoubrey, et al.
Pageof 1